Repare Therapeutics stock soars after Gilead Sciences deal for cancer drug
Repare Therapeutics stock soars after Gilead Sciences deal for cancer drug
Source link
Similar Posts
2nd Look at Local Housing Markets in September
by Calculated Risk on 10/22/2025 02:27:00 PM Today, in the Calculated Risk Real Estate Newsletter: 2nd Look at Local Housing Markets in September A brief excerpt: The NAR is scheduled to release September Existing Home sales on Thursday, October 23rd at 10:00 AM. The consensus is for the NAR to report sales of 4.06 million…
Bank of America Corp DE Purchases 871,370 Shares of Ares Capital Co. (NASDAQ:ARCC)
Bank of America Corp DE grew its position in shares of Ares Capital Co. (NASDAQ:ARCC – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,951,926 shares of the inves Source link
China's Premier Li proposes global AI cooperation organisation
China's Premier Li proposes global AI cooperation organisation Source link
Arcutis Biotherapeutics, Inc. (ARQT) Q3 2024 Earnings Call Transcript
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Latha Vairavan – Vice President, Finance and Investor RelationsFrank Watanabe – President and CEOTodd Edwards – Chief Commercial OfficerPatrick Burnett – Chief Medical OfficerDavid Topper – Chief Financial Officer Conference Call Participants Vikram Purohit – Morgan StanleySeamus Fernandez…
A pivotal ASX stock for the ‘Last Oil Boom’ – Fat Tail Daily
It’s James Cooper here. Today’s Fat Tail Daily orbits around a single ASX stock recommendation. An urgent one. And perhaps one of the most significant in my tenure asFat Tail Investment Research’s head resource stock analyst. Let me give you the background… It’s now hard to ignore the firing-up of the Australian commodities space. Explorers…
